OverviewSuggest Edit

Morphogen-IX is a company engaged in drug discovery. It develops bone morphogenetic proteins as a therapy for the treatment for pulmonary arterial hypertension.
HQBabraham, GB


Morphogen-IX is headquartered in
Babraham, United Kingdom

Location Map

Key People/Management at Morphogen-IX

David Grainger

David Grainger

Nick Morrell

Nick Morrell

Co-Founder & CEO
Wei Li

Wei Li

Show more

Morphogen-IX Office Locations

Morphogen-IX has an office in Babraham
Babraham, GB (HQ)
Babraham Hall House
Show all (1)

Morphogen-IX Financials and Metrics

Summary Metrics

Founding Date


Morphogen-IX total Funding

$25.4 m

Morphogen-IX latest funding size

$23.27 m

Time since last funding

a year ago

Morphogen-IX investors

Morphogen-IX's latest funding round in December 2018 was reported to be $23.3 m. In total, Morphogen-IX has raised $25.4 m
Show all financial metrics

Morphogen-IX Revenue

Cash (31-Jul-2018)

GBPFY, 2017FY, 2018



Current Assets

Y, 2018

Financial Leverage

1.2 x
Show all financial metrics

Morphogen-IX Online and Social Media Presence

Embed Graph

Morphogen-IX Frequently Asked Questions

  • When was Morphogen-IX founded?

    Morphogen-IX was founded in 2015.

  • Who are Morphogen-IX key executives?

    Morphogen-IX's key executives are David Grainger, Nick Morrell and Wei Li.

  • Who are Morphogen-IX competitors?

    Competitors of Morphogen-IX include Horizon Therapeutics, Vitality Biopharma and Opiant Pharmaceuticals.

  • Where is Morphogen-IX headquarters?

    Morphogen-IX headquarters is located at Babraham Hall House, Babraham.

  • Where are Morphogen-IX offices?

    Morphogen-IX has an office in Babraham.

  • How many offices does Morphogen-IX have?

    Morphogen-IX has 1 office.